Two patients suffering from NSCLC with a novel rearrangement mutation in RET (exon2-11del) and their response to pralsetinib as salvage treatment

Affiliations

• ¹ Department of Lung Cancer Center, The Second Affiliated Hospital of Nanchang University, 1Minde Road, Nanchang, Jiangxi, China; Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1Minde Road, Nanchang, Jiangxi, China.
• ² Department of Lung Cancer Center, The Second Affiliated Hospital of Nanchang University, 1Minde Road, Nanchang, Jiangxi, China; Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1Minde Road, Nanchang, Jiangxi, China. Electronic address: huanglongdoctor@163.com.